is conditionally recommended over addition of a bDMARD or tsDMARD for patients with a serious infection within the previous 12 months who have moderate-to-high disease activity despite csDMARD monotherapy This conditional recommendation is made based on observational data suggesting a lower risk of infection associated with combination csDMARDs (dual or triple therapy) compared to bDMARDs or tsDMARDs Addition of/switching to DMARDs is conditionally recommended over initiation/dose escalation of glucocorticoids for patients with a serious infection within the previous 12 months who have moderate-to-high disease activity This conditional recommendation is made based on observational studies suggesting a strong association between dose and duration of glucocorticoids with the risk of serious infection Nontuberculous mycobacterial (NTM) lung disease Given the variability of NTM lung disease severity and response to treatment, patients should be closely comanaged with an infectious disease